These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 25483564)

  • 1. Clinical, economic and societal impact of antibiotic resistance.
    Barriere SL
    Expert Opin Pharmacother; 2015 Feb; 16(2):151-3. PubMed ID: 25483564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial stewardship: bridging the gap between quality care and cost.
    Goff DA
    Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S11-20. PubMed ID: 21200180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluations of antibiotic use and resistance--a perspective: report of Task Force 6.
    Liss RH; Batchelor FR
    Rev Infect Dis; 1987; 9 Suppl 3():S297-312. PubMed ID: 3299649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of antibiotic stewardship in extending the age of modern medicine.
    Mendelson M
    S Afr Med J; 2015 Apr; 105(5):414-8. PubMed ID: 26242674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to antibiotics: are we in the post-antibiotic era?
    Alanis AJ
    Arch Med Res; 2005; 36(6):697-705. PubMed ID: 16216651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial sensitivity--A natural resource to be protected by a Pigouvian tax?
    Vågsholm I; Höjgård S
    Prev Vet Med; 2010 Aug; 96(1-2):9-18. PubMed ID: 20570379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.
    Evans ME; Feola DJ; Rapp RP
    Ann Pharmacother; 1999 Sep; 33(9):960-7. PubMed ID: 10492501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance as a major public health concern: epidemiology and economic impact.
    Ciorba V; Odone A; Veronesi L; Pasquarella C; Signorelli C
    Ann Ig; 2015; 27(3):562-79. PubMed ID: 26152543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The other side of the coin: socioeconomic analysis of antibiotic resistance].
    García-Altés A; Jovell AJ; Aymerich M
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():27-31. PubMed ID: 10605187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of antibiotic use in adult dairy cows on antimicrobial resistance of veterinary and human pathogens: a comprehensive review.
    Oliver SP; Murinda SE; Jayarao BM
    Foodborne Pathog Dis; 2011 Mar; 8(3):337-55. PubMed ID: 21133795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections.
    Li J; Nation RL; Turnidge JD; Milne RW; Coulthard K; Rayner CR; Paterson DL
    Lancet Infect Dis; 2006 Sep; 6(9):589-601. PubMed ID: 16931410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic consequences of antimicrobial resistance.
    Paladino JA; Sunderlin JL; Price CS; Schentag JJ
    Surg Infect (Larchmt); 2002; 3(3):259-67. PubMed ID: 12542927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economics of antibiotic resistance.
    Sipahi OR
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):523-39. PubMed ID: 18662118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of colistin-containing products within the European Union and European Economic Area (EU/EEA): development of resistance in animals and possible impact on human and animal health.
    Catry B; Cavaleri M; Baptiste K; Grave K; Grein K; Holm A; Jukes H; Liebana E; Lopez Navas A; Mackay D; Magiorakos AP; Moreno Romo MA; Moulin G; Muñoz Madero C; Matias Ferreira Pomba MC; Powell M; Pyörälä S; Rantala M; Ružauskas M; Sanders P; Teale C; Threlfall EJ; Törneke K; van Duijkeren E; Torren Edo J
    Int J Antimicrob Agents; 2015 Sep; 46(3):297-306. PubMed ID: 26215780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
    Nikodemski T
    Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005.
    Finch R; Hunter PA
    J Antimicrob Chemother; 2006 Sep; 58 Suppl 1():i3-i22. PubMed ID: 17003063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance diagnosis and the changing economics of antibiotic discovery.
    McAdams D
    Ann N Y Acad Sci; 2017 Jan; 1388(1):18-25. PubMed ID: 28072904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance: impact on clinical and economic outcomes and the need for new antimicrobials.
    Thabit AK; Crandon JL; Nicolau DP
    Expert Opin Pharmacother; 2015 Feb; 16(2):159-77. PubMed ID: 25496207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial stewardship in paediatrics.
    Principi N; Esposito S
    BMC Infect Dis; 2016 Aug; 16(1):424. PubMed ID: 27538503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance.
    Viganor L; Howe O; McCarron P; McCann M; Devereux M
    Curr Top Med Chem; 2017; 17(11):1280-1302. PubMed ID: 27697043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.